2023
Trends and impact of intravascular ultrasound and optical coherence tomography on percutaneous coronary intervention for myocardial infarction
Park D, Vemmou E, An S, Nikolakopoulos I, Regan C, Cambi B, Frampton J, Vij A, Brilakis E, Nanna M. Trends and impact of intravascular ultrasound and optical coherence tomography on percutaneous coronary intervention for myocardial infarction. IJC Heart & Vasculature 2023, 45: 101186. PMID: 36852085, PMCID: PMC9957744, DOI: 10.1016/j.ijcha.2023.101186.Peer-Reviewed Original ResearchIntravascular imaging-guided percutaneous coronary interventionImaging-guided percutaneous coronary interventionPercutaneous coronary interventionOptical coherence tomographyMyocardial infarctionIntravascular ultrasoundCoronary interventionIntravascular imagingIVUS-guided percutaneous coronary interventionCoherence tomographyNumber of PCIsNational Inpatient SampleMultivariable logistic regressionCochran-Armitage trend testIVUS useHospital mortalityClinical outcomesOCT guidanceInpatient SampleImproved outcomesLower oddsLower mortalityLogistic regressionContinuous outcomesOutcomes
2020
Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction
Megaly M, Buda KG, Xenogiannis I, Vemmou E, Nikolakopoulos I, Saad M, Rinfret S, Abbott JD, Aronow HD, Garcia S, Pershad A, Burke MN, Brilakis ES. Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction. Cardiovascular Intervention And Therapeutics 2020, 36: 481-489. PMID: 33037991, DOI: 10.1007/s12928-020-00713-y.Peer-Reviewed Original ResearchConceptsDrug-coated balloonsAcute myocardial infarctionMyocardial infarctionAMI patientsOutcomes of DCBMajor adverse cardiovascular eventsAdverse cardiovascular eventsLate lumen lossShort-term outcomesLesion revascularizationCardiovascular eventsCause mortalityAngiographic outcomesCardiac deathLumen lossSimilar riskClinical utilityPatientsSystematic reviewLarger studyInfarctionStatistical differenceOutcomesMonthsBalloonCoronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis
Megaly M, Glogoza M, Xenogiannis I, Vemmou E, Nikolakopoulos I, Omer M, Saad M, Willson L, Monyak DJ, Sullivan P, Pershad A, Chavez I, Mooney M, Traverse J, Wang Y, Garcia S, Poulose A, Burke MN, Brilakis ES. Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine 2020, 23: 28-35. PMID: 32883584, DOI: 10.1016/j.carrev.2020.08.035.Peer-Reviewed Original ResearchConceptsTarget vessel revascularizationIncidence of TVRIncidence of MIRecurrent ISRMyocardial infarctionCause mortalityStent restenosisSystematic reviewIntravascular brachytherapyOutcomes of interestVessel revascularizationCoronary DrugObservational studyMeta-AnalysisIncidencePrevious treatmentBrachytherapyTwo yearsPatientsRestenosisMortalityStentsOutcomesTreatmentLimited studies